Ads are not an endorsement by the blog author.

Disorders of the Lymph System

Public Journal
 Back to Journal Archives | Subscribe to Alerts Alerts Subscribe to Alerts | Feeds
< The potential eff
Tuesday, April 22, 2008
Lymphedema People >
Sunday, June 1, 2008
May 2008
B-cell lymphoma with febrile inflammatory lymphoedema of the lower limbs and lower back
« May 2008 Archive
Wednesday, May 14, 2008
Subject: B-cell lymphoma with febrile inflammatory lymphoedema of the lower limbs and lower back
Time: 6:11:00 AM EDT
Author:  patoco2


B-cell lymphoma with febrile inflammatory lymphoedema of the lower limbs and lower back

Ann Dermatol Venereol. 2008 Apr

Pallure V, Dandurand M, Stoebner PE, Habib F, Colonna G, Meunier L.

Service de dermatologie, groupe hospitalo-universitaire Carémeau, rue du Professeur-Robert-Debré, 30900 Nîmes, France.

BACKGROUND: Intravascular lymphomas are diffuse large-cell lymphomas belonging to a group of high-grade non-Hodgkin's lymphomas and are generally of phenotype B. They are rare and carry a severe prognosis. Clinical polymorphism is dominated by neurological and cutaneous involvement.

PATIENTS AND METHODS: We report the case of an 80-year-old woman with cutaneous intravascular B-cell lymphoma as revealed by an isolated episode of febrile bilateral inflammatory lymphoedema. Following combined chemotherapy with rituximab and mini-CHOP (cyclophosphamide, adriamycin, oncovin and prednisone), complete remission was obtained rapidly, with no relapse at two years.

DISCUSSION: Diagnosis of these tumors is rendered difficult by the clinical polymorphism and multifocal nature of lymphocytic proliferations. In the present case, diagnosis was based on histology results since presentation of the disease in the form of bilateral inflammatory oedema of the lower limbs is not sufficient to establish lymphoma. Combined rituximab and polychemotherapy comprising a CHOP regimen appears to yield the best results.

Keywords: Intravascular B-cell lymphoma; Lymphedema

Elsevier



Written by patoco2 Blog about this entry
This entry has 0 comments: (Add your own)